Sonya Del Tredici and John Keenan
Sonya Del Tredici and John Keenan
21. SOAT for OUD: Short-Acting Opioid Agonists for Opioid Use Disorder
21. SOAT for OUD: Short-Acting Opioid Agonists for Opioid Use Disorder
21. SOAT for OUD: Short-Acting Opioid Agonists for Opioid Use Disorder
Monday 22nd May 2023
Join Drs. Del Tredici and Keenan as they discuss short-acting opioid agonists for opioid use disorder, involuntary treatment, and Juul's lawsuit.
38 minutes
Informative
Thought-provoking
Compassionate
Engaging
Eye-opening
About this podcast
Author:
Sonya Del Tredici and John Keenan
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Episodes:
56 (View all)
Do you want to link to this podcast?
Get the buttons here!Rethinking Opioid Treatment: Short-Acting Solutions and Controversial Topics
Episode Overview
- The episode explores the groundbreaking study on using short-acting opioid agonists for treating opioid use disorder in hospitalized patients
- The hosts offer unique insights into involuntary treatment for addiction and its impact on patients
- The discussion covers the Juul lawsuit, raising awareness about the marketing of e-cigarettes to minors
- Insights into the challenges of addiction medicine practice and the need for evidence-based, compassionate treatment options are shared
- The episode provides valuable reflections on patient-centered addiction care and the importance of voluntary, low-barrier treatment options
The evidence is quite clear that addiction is a treatable health condition and what works is a voluntary, welcoming, low-barrier treatment that includes a range of options based on science, delivered with compassion, and centered on and driven by patients.
Imagine you're in a hospital, grappling with opioid use disorder. Traditional treatments might not be working, and the clock is ticking. That's where this episode of the 'Addiction Medicine Journal Club' podcast comes in. Hosted by Dr. Sonya Del Tredici and Dr. John Keenan, the episode dives into a fascinating study on using short-acting opioid agonists for treating hospitalized patients with opioid use disorder. It's a fresh take that could change how we think about addiction treatment in critical settings.
But that's not all. The hosts also tackle the thorny issue of involuntary treatment for addiction. Is it a lifeline or a risky gamble? Dr. Del Tredici and Dr. Keenan share their perspectives, drawing from both research and real-world experience. Their discussion raises important questions about patient autonomy and the ethics of forced interventions. And if you're curious about the latest buzz in the world of e-cigarettes, you'll find the segment on Juul's legal troubles particularly enlightening.
With Juul facing a hefty lawsuit over youth addiction claims, the hosts break down what this means for public health and future regulations. Throughout the episode, Drs. Del Tredici and Keenan provide a blend of clinical insights and compassionate care strategies. Whether you're a healthcare professional or someone interested in addiction treatment, this episode offers valuable takeaways that challenge conventional wisdom and highlight the importance of evidence-based approaches.
So, if you're ready to rethink opioid treatment and explore some of the most pressing issues in addiction medicine today, tune in to this episode. It's a conversation that's as engaging as it is informative, shedding light on new paths to recovery.